Board Name | Posts By roccomi | Post Created |
---|---|---|
AMBS Amarantus Bioscience Holdings | Maybe true just for Wolframs. It co | 11/20/2014 11:16:02 AM |
Recent Articles
- Leeward Renewable Energy's Q3 2024 Financial Results Update
- Union Pacific Corporation Announces Consistent Dividend Commitment
- Pinnacle Bancshares Announces $0.27 Quarterly Dividend for Shareholders
- Regional Management Corp. Achieves Milestone with New Securitization
- BNY Mellon Municipal Funds Announce Monthly Distributions
- Sandstorm Gold Enhances Production and Key Developments Update
- Valante Capital Strengthens Position with American Foods Acquisition
- Essential Steps for Securing Your Construction Loan Guide
- Digital Ally, Inc. Improves Compliance After Nasdaq Notification
- Royalty Pharma Expands Investor Engagement with Conferences
- ARMOUR Residential REIT Enhances December Dividend for Shareholders
- Quanex Building Products to Share 2024 Earnings Insights Soon
- Fundamental Global Inc. Announces Exciting Cash Dividend Update
- OneMedNet Corporation Faces Nasdaq Compliance Challenge
- Nutanix Set to Showcase Innovations at Key Investor Event
- Coherus BioSciences: Insights on Upcoming Healthcare Panel
- Marten Transport Announces Consistent Quarterly Dividend Payout
- Wing Yip Food Holdings Complete First Public Offering Success
- Globus Maritime to Announce Q3 and Nine-Month Results Soon
- Windtree Therapeutics Unveils Recent Financial Update and Insights
- Revolution Medicines to Update on Innovative RAS(ON) Therapies
- Sensei Biotherapeutics Eyes Opportunities at Upcoming Conference
- Atara Biotherapeutics Set to Showcase Innovations at Key Conference
- Innovative Tools from QIAGEN Revolutionize Microbial Analysis
- Parsons Corporation Engages Investors at Upcoming Conferences
- Glancy Prongay & Murray Probes ICON Public Limited Company Violations
- Titan Pharmaceuticals Faces Compliance Challenges with Nasdaq
- Exploring Opportunities for Hasbro, Inc. Investors Amidst Recent Lawsuit
- Applied Therapeutics Updates on Govorestat FDA Response
- Investigation of MediaAlpha, Inc. Sparks Attention for Investors
- Investigation Into Marqeta, Inc.: Key Insights for Investors
- Regeneron Pharmaceuticals Under Investigation by GPM: What Investors Need to Know
- PACS Group, Inc. Faces Class Action Amid Allegations of Fraud
- Investigation into Franklin Resources Signals Investor Concerns
- First Trust Advisors L.P. Declares Monthly Distribution for ETF
- Revolutionizing Robotics: WorkFar's Remarkable Journey Ahead
- Harley-Davidson Announces Fourth Quarter Dividend for 2024
- ASML Holding NV Class Action: What Investors Need to Know
- Boardwalktech Software: Fiscal 2025 Q2 Results Overview
- Transforming Tupperware: A New Era for Party Products LLC
- Kewaunee Scientific Corporation Announces Upcoming Earnings
- Ramaco Resources Closes Senior Unsecured Notes Offering Successfully
- iClick Interactive Reports Strong Half-Year Financial Performance
- Ohio Senator's Visit Highlights Blossom Hill's Impact on Disabled Community
- Revolutionizing Steel Maintenance: Laser Photonics CleanTech
- WellRX Enhances Preventative Care With Bioreach Acquisition
- Insights for Investors in Warner Bros. Discovery, Inc. (WBD)
- Experience the Thrill of Survival with PattieSquidGame Season 2
- Rumble Challenges California's Censorship Law in Court
- APPlife Digital Solutions Ends Collaboration with Silver Bear